MedPath

To study if a smaller dose of propofol given prior to the actual dose will be able to reduce its total dose required.

Not Applicable
Conditions
Health Condition 1: K35-K38- Diseases of appendixHealth Condition 2: H65-H75- Diseases of middle ear and mastoidHealth Condition 3: K80-K87- Disorders of gallbladder, biliary tract and pancreasHealth Condition 4: K40-K46- HerniaHealth Condition 5: C73-C75- Malignant neoplasms of thyroid and other endocrine glands
Registration Number
CTRI/2020/06/025742
Lead Sponsor
REEHANA JABARULLA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

ASA 1 and 2

Exclusion Criteria

H/O allergy to egg, opioids

Alcoholics

H/O intake of CNS depressants

ASA 3 and 4

Haemodynamic instability

BMI > 35

Anticipated difficult intubation

Pregnancy and lactating mothers

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To Study the Effect of Priming Principle on the Induction dose requirement of Propofol.Timepoint: 1 year
Secondary Outcome Measures
NameTimeMethod
To Compare the Hemodynamics between the group in which Priming Principle was applied and the group in which No priming was applied. <br/ ><br> <br/ ><br>Timepoint: 1 year
© Copyright 2025. All Rights Reserved by MedPath